These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37629280)

  • 1. Examining the Role of Sublingual Atropine for the Treatment of Sialorrhea in Patients with Neurodevelopmental Disabilities: A Retrospective Review.
    Petkus KD; Noritz G; Glader L
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycopyrrolate for chronic drooling in children.
    Eiland LS
    Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual Atropine Sulfate Use for Sialorrhea in Pediatric Patients.
    Azapağası E; Kendirli T; Perk O; Kutluk G; Öz Tunçer G; Teber S; Çobanoğlu N
    J Pediatr Intensive Care; 2020 Sep; 9(3):196-200. PubMed ID: 32685247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.
    Formeister EJ; Dahl JP; Rose AS
    Int J Pediatr Otorhinolaryngol; 2014 Aug; 78(8):1387-92. PubMed ID: 24974144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of atropine in managing sialorrhea: A systematic review and meta-analysis.
    Yellepeddi VK; Race JA; McFarland MM; Constance JE; Fanaeian E; Murphy NA
    Int J Clin Pharmacol Ther; 2024 Jun; 62(6):267-277. PubMed ID: 38577753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycopyrrolate for drooling in children with medical complexity under three years of age.
    Lovardi E; De Ioris MA; Lettori D; Geremia C; Staccioli S; Bella GD; Scrocca R; Scarselli A; Aversa M; De Peppo F; Campana A; Castelli E
    Ital J Pediatr; 2022 Jan; 48(1):2. PubMed ID: 34998418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-year Retrospective Review of Botulinum Toxin Injections and Surgical Management of Sialorrhea.
    Weitzman RE; Kawai K; Nuss R; Hughes A
    Cureus; 2020 May; 12(5):e7916. PubMed ID: 32494530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary gland ablation: introducing an interventional radiology treatment alternative in the management of sialorrhea.
    Begley KA; Braswell LE; Noritz GH; Murakami JW
    Pediatr Radiol; 2020 May; 50(6):869-876. PubMed ID: 32198665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic.
    Montgomery J; McCusker S; Lang K; Grosse S; Mace A; Lumley R; Kubba H
    Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():33-9. PubMed ID: 27240493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy.
    Dias BLS; Fernandes AR; Maia HS
    Arq Neuropsiquiatr; 2017 May; 75(5):282-287. PubMed ID: 28591387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
    Mubaslat O; Lambert T
    Psychopharmacology (Berl); 2020 Oct; 237(10):2905-2915. PubMed ID: 32876732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drooling outcome measures in paediatric disability: a systematic review.
    Sforza E; Onesimo R; Leoni C; Giorgio V; Proli F; Notaro F; Kuczynska EM; Cerchiari A; Selicorni A; Rigante D; Zampino G
    Eur J Pediatr; 2022 Jul; 181(7):2575-2592. PubMed ID: 35441248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual administration of atropine eyedrops in children with excessive drooling - a pilot study.
    Norderyd J; Graf J; Marcusson A; Nilsson K; Sjöstrand E; Steinwall G; Ärleskog E; Bågesund M
    Int J Paediatr Dent; 2017 Jan; 27(1):22-29. PubMed ID: 26708211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Management of Sialorrhea in Neonatal and Pediatric Patients.
    Bradford CV; Parman AM; Johnson PN; Miller JL
    J Pediatr Pharmacol Ther; 2024; 29(1):6-21. PubMed ID: 38332959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycopyrrolate treatment of chronic drooling.
    Blasco PA; Stansbury JC
    Arch Pediatr Adolesc Med; 1996 Sep; 150(9):932-5. PubMed ID: 8790123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of submandibular duct relocation on drooling and the well-being of children with neurodevelopmental disabilities.
    Kok SE; van der Burg JJ; van Hulst K; Erasmus CE; van den Hoogen FJ
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():173-8. PubMed ID: 27497408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
    Hay N; Penn C
    Int J Lang Commun Disord; 2011; 46(5):550-63. PubMed ID: 21899672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
    Savarese R; Diamond M; Elovic E; Millis SR
    Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review.
    Rodwell K; Edwards P; Ware RS; Boyd R
    Dev Med Child Neurol; 2012 Nov; 54(11):977-87. PubMed ID: 22946706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study.
    Hyson HC; Johnson AM; Jog MS
    Mov Disord; 2002 Nov; 17(6):1318-20. PubMed ID: 12465075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.